ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.verified

ZVSA

Price:

$0.247

Market Cap:

$2.00M

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.

Industry

Biotechnology

IPO Date

2022-02-11

Stock Exchange

NASDAQ

Ticker

ZVSA

The Enterprise Value as of March 2026 (TTM) for ZyVersa Therapeutics, Inc. (ZVSA) is 1.47M

According to ZyVersa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.47M. This represents a change of -86.42% compared to the average of 10.83M of the last 4 quarters.

ZyVersa Therapeutics, Inc. (ZVSA) Historical Enterprise Value (quarterly & annually)

How has ZVSA Enterprise Value performed in the past?

The mean historical Enterprise Value of ZyVersa Therapeutics, Inc. over the last ten years is 67.79M. The current 1.47M Enterprise Value has changed 117.09% with respect to the historical average. Over the past ten years (40 quarters), ZVSA's Enterprise Value was at its highest in in the March 2022 quarter at 170.95M. The Enterprise Value was at its lowest in in the December 2024 quarter at -380506.00.

Quarterly (TTM)
Annual

Average

67.79M

Median

8.45M

Minimum

-2251491.00

Maximum

169.15M

ZyVersa Therapeutics, Inc. (ZVSA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ZyVersa Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.16%

Maximum Annual Enterprise Value = 169.15M

Minimum Annual Increase = -126.64%

Minimum Annual Enterprise Value = -2251491.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-354289.02-84.26%
2023-2251491.00-126.64%
20228.45M-95.00%
2021169.15M3.16%

ZyVersa Therapeutics, Inc. (ZVSA) Average Enterprise Value

How has ZVSA Enterprise Value performed in the past?

The current Enterprise Value of ZyVersa Therapeutics, Inc. (ZVSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.95M

5-year avg

67.79M

10-year avg

67.79M

ZyVersa Therapeutics, Inc. (ZVSA) Enterprise Value vs. Peers

How is ZVSA’s Enterprise Value compared to its peers?

ZyVersa Therapeutics, Inc.’s Enterprise Value is greater than Hepion Pharmaceuticals, Inc. (-1076777.00), less than CDT Equity Inc. (990.95M), greater than Enveric Biosciences, Inc. (-2611331.00), greater than Longevity Health Holdings Inc. (-75149.00), less than NewGenIvf Group Limited (5.22M), greater than SCWorx Corp. (-96669.00), greater than Indaptus Therapeutics, Inc. (-2665121.00), greater than Jasper Therapeutics, Inc. (-28555236.00), greater than Onconetix, Inc. (-343249.00), greater than Silexion Therapeutics Ltd. (-7823266.00),

CompanyEnterprise ValueMarket cap
-1076777.00$697.22K
990.95M$797.81K
-2611331.00$1.15M
-75149.00$415.45K
5.22M$12.19K
-96669.00$584.78K
-2665121.00$3.15M
-28555236.00$20.64M
-343249.00$326.88K
-7823266.00$934.73K

Build a custom stock screener for ZyVersa Therapeutics, Inc. (ZVSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZyVersa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ZyVersa Therapeutics, Inc. (ZVSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ZyVersa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ZyVersa Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?

What is the 3-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?

What is the 5-year average Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA)?

How does the current Enterprise Value for ZyVersa Therapeutics, Inc. (ZVSA) compare to its historical average?